LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Suletud

Sektor Tervishoid

66.76 1.26

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

66.52

Max

67.02

Põhinäitajad
By Trading Economics
Sissetulek	14M 366M
Müük	30M 1.6B
P/E Sektori keskmine	39.81 103.001
Aktsiakasum	0.7
Kasumimarginaal	22.472
Töötajad	19,800
EBITDA	-59M 417M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+20.64 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	23. okt 2024

Turustatistika
By TradingEconomics
Turukapital	-289M 42B
Eelmine avamishind	65.5
Eelmine sulgemishind	66.76

Uudiste sentiment

By Acuity

50%

287 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

64.7 / 68.66 Toetus ja vastupanu

Edwards Lifesciences Corp Graafik

Seotud uudised

15. juuli 2024, 13:57 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Buy Innovalve for $300 Million

3. sept 2024, 20:38 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3. sept 2024, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3. sept 2024, 20:36 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25. juuli 2024, 09:02 UTC

Tulu

Kuumad aktsiad

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25. juuli 2024, 08:40 UTC

Peamised uudised

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24. juuli 2024, 20:17 UTC

Tulu

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24. juuli 2024, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Sales $1.39B >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Net $366.3M >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q Adj EPS 70c >EW

24. juuli 2024, 20:15 UTC

Tulu

Edwards Lifesciences 2Q EPS 61c >EW

15. juuli 2024, 13:42 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Buy Innovalve for $300M

15. juuli 2024, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15. juuli 2024, 13:01 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15. juuli 2024, 13:00 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15. juuli 2024, 13:00 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences To Acquire Innovalve >EW

4. juuni 2024, 17:26 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3. juuni 2024, 13:26 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3. juuni 2024, 12:25 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3. juuni 2024, 11:03 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3. juuni 2024, 10:40 UTC

Omandamised, ülevõtmised, äriostud

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3. juuni 2024, 10:32 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3. juuni 2024, 10:31 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3. juuni 2024, 10:31 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3. juuni 2024, 10:30 UTC

Omandamised, ülevõtmised, äriostud

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3. juuni 2024, 10:30 UTC

Omandamised, ülevõtmised, äriostud

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26. apr 2024, 20:10 UTC

Tulu

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

25. apr 2024, 21:05 UTC

Tulu

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

25. apr 2024, 20:32 UTC

Tulu

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

Võrdlus sarnastega

Hinnamuutus

Edwards Lifesciences Corp Prognoos

Hinnasiht

By TipRanks

20.64% tõus

12 kuu keskmine prognoos

Keskmine 80.6 USD 20.64%

Kõrge 91 USD

Madal 70 USD

Põhineb 23 Wall Streeti analüütiku instrumendi Edwards Lifesciences Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

23 ratings

Osta

Hoia

Müü

Põhineb 23 analüütiku instrumendi Edwards Lifesciences Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

64.7 / 68.66Toetus ja vastupanu

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

287 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

EBITDA

Ärikasum

Ettevõttest Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.